Virtual CT navigation image of the hepato-biliary system

肝胆系统虚拟CT导航图像

基本信息

  • 批准号:
    14570892
  • 负责人:
  • 金额:
    $ 1.73万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2002
  • 资助国家:
    日本
  • 起止时间:
    2002 至 2003
  • 项目状态:
    已结题

项目摘要

Seventy-four consecutive patients were referred for the evaluation of hepatobiliary disease after discovery based on clinical symptoms and ultrasound. The CT scan started at the level of the diaphragm and covered the entire liver, common bile duct and pancreas. Using a power injector, contrast medium was injected through a 20-G high-pressure intravenous catheter at a rate of 4 mL/sec in an antecubital vein. The volume of contrast medium delivered was 2 mL per kilogram of body weight. Fourteen patients who underwent percutaneous transhepatic bileduct drainage (PTBD) to eliminate obstructive jaundice were injected by PTBD tube of contrast medium in addition to intravenous injection. The raw data was transferred automatically to a workstation in a 512 x 512 pixel format via Ethernet. The 3-or 4-phase source 2D CT images were reviewed and analyzed for 3D reconstruction and to obtain a fusion image. Virtual CT navigation image were obtained using virtual endoscopic technique on the workstation. These images were analyzed qualitatively based on visualization of the critical structures. While evaluating these frill scale-3D and virtual images obtained by our institute, these images were clearly depicted in most of cases. The depict of organs can be reconstructed while there were a significant difference of attenuation value between the organ and a region around structure, but the several cases were difficult to produce 3D image in small size and the equal attenuation value around the structure. We emphasize that our new technique may contribute to the laparoscopy during surgery as the aid of understanding of anatomical structures in these organs. Our images are extremely helpful to the surgeon in localizing lesions and minimizing operating time, the extent of surgical resection, and blood loss.
根据临床症状和超声发现后,连续74例患者被转诊进行肝胆疾病评价。CT扫描从横膈膜开始,覆盖了整个肝脏、胆总管和胰腺。使用动力注射器,通过20-G高压静脉导管以4 mL/sec的速率在肘前静脉中注射造影剂。造影剂的递送体积为每千克体重2 mL。对14例行经皮经肝胆管引流(PTBD)清除梗阻性黄疸的患者,除静脉注射造影剂外,还用PTBD管注入造影剂。原始数据通过以太网以512 x 512像素格式自动传输到工作站。对3期或4期源2D CT图像进行审查和分析,以进行3D重建并获得融合图像。在工作站上采用虚拟内窥镜技术获得虚拟CT导航图像。这些图像进行了定性分析的基础上可视化的关键结构。在评价我们所获得的这些三维和虚拟图像时,这些图像在大多数情况下都被清晰地描绘出来。当器官与周围结构的衰减值存在显著差异时,可以重建器官的轮廓,但在几种情况下,很难产生小尺寸和结构周围等衰减值的3D图像。我们强调,我们的新技术可能有助于腹腔镜手术中的解剖结构的理解,在这些器官的援助。我们的图像对外科医生定位病变和减少手术时间、手术切除范围和失血量非常有帮助。

项目成果

期刊论文数量(40)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
内田政史: "肝・胆道のvirtual CT navigation image作成の試み"日本コンピューター支援外科学会会誌. 9・4. 62-66 (2002)
Masashi Uchida:“尝试创建肝脏和胆道的虚拟 CT 导航图像”日本计算机辅助外科学会杂志 9/4 (2002)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
内田政史: "肝・胆道のvirtual CT navigation image作成の試み"日本コンピューター支援外科学会会誌. 9(4). 62-66 (2002)
Masashi Uchida:“尝试创建肝脏和胆道的虚拟 CT 导航图像”日本计算机辅助外科学会杂志 9(4) (2002)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Masafumi Uchida: "Rotational Three-dimensional Cholangiography-Initial Clinical Experience-"Radiation Medicine. 20(4). 213-215 (2002)
内田雅文:《旋转三维胆管造影-初步临床经验-》放射医学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
内田政史: "なるほど 医用三次元画像 第6章 応用編 13,14"秀潤社. 335 (2003)
内田正史:“原来如此。医学三维图像第6章应用版13,14”《书俊社》335(2003)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
内田政史(分担): "なるほど 医用三次元画像 第6章 応用編 13,14"秀潤社. 335 (2003)
内田正史(撰稿人):“我明白了。医学三维图像第6章应用版13,14” Shujunsha 335(2003)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

UCHIDA Masafumi其他文献

UCHIDA Masafumi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('UCHIDA Masafumi', 18)}}的其他基金

Paradigm Design of Personal Identification by Using Tactile Sensor Fusion of Phantom Sensation and Apparent Movement
利用幻觉与表观运动融合的触觉传感器进行个人识别的范式设计
  • 批准号:
    21500511
  • 财政年份:
    2009
  • 资助金额:
    $ 1.73万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Multiphase fusion image of the hepato-biliary system
肝胆系统多相融合图像
  • 批准号:
    18591370
  • 财政年份:
    2006
  • 资助金额:
    $ 1.73万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A study on information transmission by using sensor fusion of phantom sensation and apparent movement
幻觉与视动传感器融合信息传输研究
  • 批准号:
    17500348
  • 财政年份:
    2005
  • 资助金额:
    $ 1.73万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Simulation and Navigation image of the hepato-biliary system using MD-CT
MD-CT肝胆系统模拟与导航图像
  • 批准号:
    16591236
  • 财政年份:
    2004
  • 资助金额:
    $ 1.73万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似国自然基金

肝受体类似物(Liver Receptor Homolog 1, LRH 1)在雌鼠生殖过程中的作用及其机制
  • 批准号:
    31172040
  • 批准年份:
    2011
  • 资助金额:
    59.0 万元
  • 项目类别:
    面上项目

相似海外基金

HoloSurge: Multimodal 3D Holographic tool and real-time Guidance System with point-of-care diagnostics for surgical planning and interventions on liver and pancreatic cancers
HoloSurge:多模态 3D 全息工具和实时指导系统,具有护理点诊断功能,可用于肝癌和胰腺癌的手术规划和干预
  • 批准号:
    10103131
  • 财政年份:
    2024
  • 资助金额:
    $ 1.73万
  • 项目类别:
    EU-Funded
GPR35: mechanisms of action and agonism as a potential therapeutic strategy for non-alcoholic fatty liver diseases
GPR35:作为非酒精性脂肪肝疾病潜在治疗策略的作用和激动机制
  • 批准号:
    MR/X008827/1
  • 财政年份:
    2024
  • 资助金额:
    $ 1.73万
  • 项目类别:
    Research Grant
Atypical Chemokine Receptors orchestrate changes in vascular patterning during fibrotic liver disease via Endothelial-to-Mesenchymal Transition.
非典型趋化因子受体通过内皮-间质转化协调纤维化肝病期间血管模式的变化。
  • 批准号:
    MR/Y013751/1
  • 财政年份:
    2024
  • 资助金额:
    $ 1.73万
  • 项目类别:
    Research Grant
Investigation of Endocrine-Disrupting Chemicals as Contributors to Progression of Metabolic Dysfunction Associated Steatotic Liver Disease (EDC-MASLD)
内分泌干​​扰化学物质对代谢功能障碍相关脂肪性肝病 (EDC-MASLD) 进展的影响的调查
  • 批准号:
    10092670
  • 财政年份:
    2024
  • 资助金额:
    $ 1.73万
  • 项目类别:
    EU-Funded
Biomarker-Based Platform for Early Diagnosis of Chronic Liver Disease to Enable Personalized Therapy (LIVERAIM)
基于生物标志物的慢性肝病早期诊断平台,以实现个性化治疗(LIVERAIM)
  • 批准号:
    10087822
  • 财政年份:
    2024
  • 资助金额:
    $ 1.73万
  • 项目类别:
    EU-Funded
AcceleRating the Translation of virtual twins towards a pErsonalised Management of fatty lIver patients (Artemis)
加速虚拟双胞胎向脂肪肝患者个性化管理的转化(Artemis)
  • 批准号:
    10109933
  • 财政年份:
    2024
  • 资助金额:
    $ 1.73万
  • 项目类别:
    EU-Funded
HoloSurge:Multimodal 3D Holographic tool and real-time Guidance System with point-of-care diagnostics for surgical planning and interventions on liver and pancreatic cancers
HoloSurge:多模态 3D 全息工具和实时引导系统,具有护理点诊断功能,可用于肝癌和胰腺癌的手术规划和干预
  • 批准号:
    10109943
  • 财政年份:
    2024
  • 资助金额:
    $ 1.73万
  • 项目类别:
    EU-Funded
Pluripotent stem cell derived hepatocytes for liver failure (PUSH for LIFE)
多能干细胞衍生的肝细胞治疗肝衰竭(PUSH for LIFE)
  • 批准号:
    MR/Z503940/1
  • 财政年份:
    2024
  • 资助金额:
    $ 1.73万
  • 项目类别:
    Research Grant
Multi-modal non-invasive biomarker screening for high-risk undiagnosed liver disease
针对高危未确诊肝病的多模式非侵入性生物标志物筛查
  • 批准号:
    10073169
  • 财政年份:
    2023
  • 资助金额:
    $ 1.73万
  • 项目类别:
    Collaborative R&D
Quantitative ultrasound to improve detection and diagnosis of liver cancer
定量超声改善肝癌的检测和诊断
  • 批准号:
    490038
  • 财政年份:
    2023
  • 资助金额:
    $ 1.73万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了